CARL Stock Summary and Trading Ideas (Carlsmed | NASDAQ:CARL)

Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.

What symbol and exchange does Carlsmed shares trade?

Carlsmed trades on the NASDAQ stock market under the symbol CARL.

What is Carlsmed stock price doing today?

As of April 7, 2026, CARL stock price climbed to $9.74 with 82,138 million shares trading.

What is Carlsmed's Beta?

CARL has a beta of 2.83, meaning it tends to be more sensitive to market movements. CARL has a correlation of 0.22 to the broad based SPY ETF.

How much is Carlsmed worth?

CARL has a market cap of $258.90 million. This is considered a Small Cap stock.

How much money does Carlsmed make?

Last quarter Carlsmed reported $15 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $307,100 and exceeded earnings estimates by $.11.

What are the top ETFs holding Carlsmed?

The top ETF exchange traded funds that CARL belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.

What are the support and resistance levels for Carlsmed (CARL)?

CARL support price is $9.22 and resistance is $10.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CARL shares will trade within this expected range on the day.